Jean Bennett

Jean Bennett, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Opus Genetics, Inc. and REGENXBIO Inc. Over a trading history stretching from 3 June 2022 to 29 May 2026, the count stands at 10 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 2 June 2026 with a share grant in REGENXBIO Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.